Form 4 for NTRA Natera, Inc.
Accepted 2021-09-01 00:00:00 ET · period of report 2021-08-30 · accession 0001415889-21-004174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-01 | 2021-08-30+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | $9.54 | +17.9K | 459.9K | +4% | +$170.4K |
| DM | 2021-09-01 | 2021-08-30+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | S - Sale+OE | $121.18 | -17.9K | 455.6K | -4% | -$2.16M |
| DM | 2021-09-01 | 2021-08-30+ | NTRA | Sheena Jonathan | Dir, CO-FOUNDER | M - OptEx | $0.00 | -17.9K | 26.8K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-30 | M | A | 310 | $5.40 | 455,940 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-30 | M | A | 1,900 | $10.41 | 458,008 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-01 | M | A | 5,424 | $9.29 | 469,169 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-01 | S | D | 13,539 | $121.12 | 455,630 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2021. The Reporting Person is subject to a Lock-up Letter Agreement that expires on September 19, 2021. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement. (F3) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F4) These reported shares are subject to restrictions in the Lock-Up Letter Agreement. |
| 5 | Common | Common Stock | 2021-08-30 | M | A | 168 | $9.59 | 456,108 | D | — | — | |
| 6 | Common | Commom Stock | 2021-09-01 | M | A | 6,545 | $10.41 | 463,745 | D | — | — | |
| 7 | Common | Common Stock | 2021-09-01 | M | A | 552 | $9.59 | 457,200 | D | — | — | |
| 8 | Common | Common Stock | 2021-09-01 | M | A | 1,018 | $5.40 | 456,648 | D | — | — | |
| 9 | Common | Common Stock | 2021-08-30 | S | D | 4,320 | $121.36 | 455,630 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2021. The Reporting Person is subject to a Lock-up Letter Agreement that expires on September 19, 2021. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement. (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2021-08-30 | M | A | 1,942 | $9.29 | 459,950 | D | — | — | |
| 11 | Derivative | Stock Option (right to buy) | 2021-08-30 | M | D | 1,900 | $0.00 | 33,380 | D | $10.41 · — to 2027-06-08 | 1,900 Common Stock | (F7) The option shares vested fully and became exercisable on March 21, 2021. |
| 12 | Derivative | Stock Option (right to buy) | 2021-08-30 | M | D | 168 | $0.00 | 40,167 | D | $9.59 · — to 2026-04-07 | 168 Common Stock | (F6) The option shares vested fully and became exercisable on April 1, 2020. |
| 13 | Derivative | Stock Option (right to buy) | 2021-08-30 | M | D | 310 | $0.00 | 1,018 | D | $5.40 · — to 2024-12-09 | 310 Common Stock | (F5) The option shares vested fully and became exercisable on November 20, 2019. |
| 14 | Derivative | Stock Option (right to buy) | 2021-09-01 | M | D | 5,424 | $0.00 | 9,980 | D | $9.29 · — to 2028-03-08 | 5,424 Common Stock | (F8) The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter. |
| 15 | Derivative | Stock Option (right to buy) | 2021-09-01 | M | D | 552 | $0.00 | 39,615 | D | $9.59 · — to 2026-04-07 | 552 Common Stock | (F6) The option shares vested fully and became exercisable on April 1, 2020. |
| 16 | Derivative | Stock Option (right to buy) | 2021-09-01 | M | D | 1,018 | $0.00 | 0 | D | $5.40 · — to 2024-12-09 | 1,018 Common Stock | (F5) The option shares vested fully and became exercisable on November 20, 2019. |
| 17 | Derivative | Stock Option (right to buy) | 2021-08-30 | M | D | 1,942 | $0.00 | 15,404 | D | $9.29 · — to 2028-03-08 | 1,942 Common Stock | (F8) The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter. |
| 18 | Derivative | Stock Option (right to buy) | 2021-09-01 | M | D | 6,545 | $0.00 | 26,835 | D | $10.41 · — to 2027-06-08 | 6,545 Common Stock | (F7) The option shares vested fully and became exercisable on March 21, 2021. |